IN SILICO INVESTIGATION AND DOCKING STUDIES OF E2F3 TUMOR MARKER: DISCOVERY AND EVALUATION OF POTENTIAL INHIBITORS FOR PROSTATE AND BREAST CANCER. Int. J. Pharm. Sci. Drug Res. 2010, 2 (4), 254-260. https://doi.org/10.25004/IJPSDR.2010.020405.